Goldman Sachs Group Inc X Biotech Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 40,418 shares of XBIT stock, worth $269,183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,418
Previous 13,166
206.99%
Holding current value
$269,183
Previous $67,000
365.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XBIT
# of Institutions
49Shares Held
4.87MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$7.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$7.07 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA452KShares$3.01 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny281KShares$1.87 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL254KShares$1.69 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $203M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...